The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Somatic mutations in the genes encoding components of the spliceosome occur frequently in human neoplasms, including myeloid dysplasias and leukemias, and less often in solid tumors. One of the affected factors, U2AF1, is involved in splice site selection, and the most common change, S34F, alters a conserved nucleic acid-binding domain, recognition of the 3′ splice site, and alternative splicing of many mRNAs. However, the role that this mutation plays in oncogenesis is still unknown. Here, we uncovered a noncanonical function of U2AF1, showing that it directly binds mature mRNA in the cytoplasm and negatively regulates mRNA translation. This splicing-independent role of U2AF1 is altered by the S34F mutation, and polysome profiling indicates that the mutation affects translation of hundreds of mRNA. One functional consequence is increased synthesis of the secreted chemokine interleukin 8, which contributes to metastasis, inflammation, and cancer progression in mice and humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genomic classification and prognosis in acute myeloid leukemia
Papaemmanuil, E., Gerstung, M., Bullinger, L., Gaidzik, V. I., Paschka, P., Roberts, N. D., Potter, N. E., Heuser, M., Thol, F., Bolli, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516192 · Cited by 4,350 · cited 2×
“Finally, we asked whether IL8 is elevated in relapsed/refractory acute myeloid leukemia (RR-AML), where spli-ceosome mutations are common (Papaemmanuil et al. 2016).”
Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP
Hafner, M., Landthaler, M., Burger, L., Khorshid, M., Hausser, J., Berninger, P., Rothballer, A., Ascano, M., Jungkamp, A.-C., Munschauer, M., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.009 · Cited by 2,873 · cited 2×
“PAR-CLIP was performed on the subcellular fractions isolated above as described previously (Hafner et al. 2010; Benhalevy et al. 2017) with a few modifications.”
Self-citationNF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679 · cited 1×
“Because of the role of inflammatory cytokines in cancer (Grivennikov et al. 2010; Taniguchi and Karin 2018), we chose to study this phenotype further.”
Frequent pathway mutations of splicing machinery in myelodysplasia
Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011) · Nature · doi:10.1038/nature10496 · Cited by 2,029 · cited 3×
“A recurrent hot-spot mutation in U2AF1 (S34F) in its first Zn-finger domain (Yoshida et al. 2011; Imielinski et al. 2012; Brooks et al. 2014) critical for RNA binding activity (Yoshida et al. 2015), alters RNA-binding specificity (Okeyo-Owuor et al. 2015; Fei et al. 2016; Jenkins and Kielkopf 2017;…”
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789 · cited 4×
“A recurrent hot-spot mutation in U2AF1 (S34F) in its first Zn-finger domain (Yoshida et al. 2011; Imielinski et al. 2012; Brooks et al. 2014) critical for RNA binding activity (Yoshida et al. 2015), alters RNA-binding specificity (Okeyo-Owuor et al. 2015; Fei et al. 2016; Jenkins and Kielkopf 2017;…”
InfluentialKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
Haferlach, T., Nagata, Y., Grossmann, V, Okuno, Y., Bacher, U., Nagae, G., Schnittger, S., Sanada, M., Kon, A., Alpermann, T., et al. (2014) · Leukemia · doi:10.1038/leu.2013.336 · Cited by 1,532
A unifying model for mTORC1-mediated regulation of mRNA translation
Thoreen, C. C., Chantranupong, L., Keys, H. R., Wang, T., Gray, N. S., & Sabatini, D. M. (2012) · Nature · doi:10.1038/nature11083 · Cited by 1,477
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., et al. (2012) · Nature · doi:10.1038/nature10912 · Cited by 1,313
Laberge, R.-M., Sun, Y., Orjalo, A. V., Patil, C. K., Freund, A., Zhou, L., Curran, S. C., Davalos, A. R., Wilson-Edell, K. A., Liu, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3195 · Cited by 1,160 · cited 2×
“Previous studies have shown IL8 expression is regulated both at the level of mRNA stability and translational control (Fan et al. 2011; Herranz et al. 2015; Laberge et al. 2015).”
Prediction of acute myeloid leukaemia risk in healthy individuals
Abelson, S., Collord, G., Ng, S. W. K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E., Barda, N., Zuzarte, P. C., Heisler, L., Sundaravadanam, Y., et al. (2018) · Nature · doi:10.1038/s41586-018-0317-6 · Cited by 850
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Herranz, N., Gallage, S., Mellone, M., Wuestefeld, T., Klotz, S., Hanley, C. J., Raguz, S., Acosta, J. C., Innes, A. J., Banito, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3225 · Cited by 788 · cited 2×
“Previous studies have shown IL8 expression is regulated both at the level of mRNA stability and translational control (Fan et al. 2011; Herranz et al. 2015; Laberge et al. 2015).”
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
Wolfe, A. L., Singh, K., Zhong, Y., Drewe, P., Rajasekhar, V. K., Sanghvi, V. R., Mavrakis, K. J., Jiang, M., Roderick, J. E., Van der Meulen, J., et al. (2014) · Nature · doi:10.1038/nature13485 · Cited by 635 · cited 2×
“2012) show greater enrichment in the U2AF1 IP than either the total pool of transcripts or another class of translationally regulated transcripts such as EIF4A-senstive mRNA (Fig. 2G; Rubio et al. 2014; Wolfe et al. 2014).”
mTOR, translation initiation and cancer
Mamane, Y., Petroulakis, E., LeBacquer, O., & Sonenberg, N. (2006) · Oncogene · doi:10.1038/sj.onc.1209888 · Cited by 607 · cited 2×
“…viability after genotoxic stress leads to a population of cells which secrete IL8 for >30 d. Translation initiation is often misregulated in cancer (Mamane et al. 2006) and the translation machinery is tightly controlled at the posttranscriptional level through the mTOR pathway, which is…”
Liu, D., & Hornsby, P. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3452 · Cited by 499
Bavik, C., Coleman, I., Dean, J. P., Knudsen, B., Plymate, S., & Nelson, P. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1716 · Cited by 453 · cited 1×
“These results bear a resemblance to the phenomenon of oncogene-induced senescence, where nonproliferating cells contribute to oncogenesis through secretion of factors into the surrounding tissue (Krtolica et al. 2001; Bavik et al. 2006; Liu and Hornsby 2007; Coppé et al. 2008).”
Ortiz-Montero, P., Londoño-Vallejo, A., & Vernot, J.-P. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0172-3 · Cited by 428 · cited 2×
“…et al. 2009; Fernando et al. 2011; Shen et al. 2014; Ortiz-Monte-ro et al. 2017), known to be induced by IL8 (Fernando et 2011; Shen et al. 2014; Ortiz-Montero et al. 2017), and is characterized by the induction of fibronectin and repression of E-Cadherin expression in epithelial cells (Kalluri…”
Alfaro, C., Teijeira, A., Oñate, C., Pérez, G., Sanmamed, M. F., Andueza, M. P., Alignani, D., Labiano, S., Azpilikueta, A., Rodriguez-Paulete, A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2463 · Cited by 417 · cited 2×
“Since IL8 also contributes to recruitment of myeloid cells that suppress an adaptive immune response (Alfaro et al. 2016; Dominguez et al. 2017), one prediction is that cells with U2AF1 mutations or perhaps splicing factor mutations in general will be refractory to immuno-therapy unless treated…”
Senescence-associated inflammatory responses: aging and cancer perspectives
Lasry, A., & Ben-Neriah, Y. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.009 · Cited by 408 · cited 2×
“Although we discovered this pathway through an altered DNA damage response, the change in secretion is present before DNA damage and, in fact, the opposing changes in IL8 and IL1 α are fundamentally different from the normal SASP response (Lasry and Ben-Neriah 2015).”
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302 · cited 1×
“These results bear a resemblance to the phenomenon of oncogene-induced senescence, where nonproliferating cells contribute to oncogenesis through secretion of factors into the surrounding tissue (Krtolica et al. 2001; Bavik et al. 2006; Liu and Hornsby 2007; Coppé et al. 2008).”
Rubio, C. A., Weisburd, B., Holderfield, M., Arias, C., Fang, E., DeRisi, J. L., & Fanidi, A. (2014) · Genome Biology · doi:10.1186/s13059-014-0476-1 · Cited by 200 · cited 2×
“2012) show greater enrichment in the U2AF1 IP than either the total pool of transcripts or another class of translationally regulated transcripts such as EIF4A-senstive mRNA (Fig. 2G; Rubio et al. 2014; Wolfe et al. 2014).”
Cited by
Roles and mechanisms of alternative splicing in cancer — implications for care
Bonnal, S. C., López-Oreja, I., & Valcárcel, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0350-x · Cited by 731
Alternative splicing and cancer: a systematic review
Zhang, Y., Qian, J., Gu, C., & Yang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00486-7 · Cited by 497
RNA-Binding Proteins Hold Key Roles in Function, Dysfunction, and Disease
Kelaini, S., Chan, C., Cornelius, V. A., & Margariti, A. (2021) · Biology · doi:10.3390/biology10050366 · Cited by 94
Schoetz, U., Klein, D., Hess, J., Shnayien, S., Spoerl, S., Orth, M., Mutlu, S., Hennel, R., Sieber, A., Ganswindt, U., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04454-5 · Cited by 74
The Role of Translation Control in Tumorigenesis and Its Therapeutic Implications
Xu, Y., & Ruggero, D. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033420 · Cited by 67
Metadata
- Authors
- Palangat, M., Anastasakis, D. G., Fei, D. L., Lindblad, K. E., Bradley, R., Hourigan, C. S., Hafner, M., & Larson, D. R.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2019-03-06
- Volume
- 33
- Issue
- 9-10
- Pages
- 482-497
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2884543844
- Cited by
- 102
- References
- 21
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.